These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 3557264

  • 1. [Prevention of kinetosis in children. Transdermal therapy with scopolamine].
    Müller M, Besch W, Steilner D.
    Fortschr Med; 1987 Feb 10; 105(4):82, 86-7. PubMed ID: 3557264
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.
    Nachum Z, Shupak A, Gordon CR.
    Clin Pharmacokinet; 2006 Feb 10; 45(6):543-66. PubMed ID: 16719539
    [Abstract] [Full Text] [Related]

  • 4. A comparison of cinnarizine and transdermal scopolamine for the prevention of seasickness in naval crew: a double-blind, randomized, crossover study.
    Gil A, Nachum Z, Tal D, Shupak A.
    Clin Neuropharmacol; 2012 Feb 10; 35(1):37-9. PubMed ID: 22139622
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Delirium due to scopolamine patch in a 4-year-old boy.
    Lin YG, Chen PH, Chang FY, Wu LT, Liao KY, Wu TC.
    J Formos Med Assoc; 2011 Mar 10; 110(3):208-11. PubMed ID: 21497284
    [Abstract] [Full Text] [Related]

  • 8. [Transdermally applied scopolamine for continuous prevention of motion sickness. Revival of a 150-year-old method].
    Becker G.
    Schweiz Rundsch Med Prax; 1985 Mar 12; 74(11):271-6. PubMed ID: 3887535
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anisocoria from scopolamine patches.
    Price BH.
    JAMA; 1985 Mar 15; 253(11):1561. PubMed ID: 3974034
    [No Abstract] [Full Text] [Related]

  • 11. Control of simulator sickness in an AH-64 aviator.
    Crowley JS.
    Aviat Space Environ Med; 1990 Jun 15; 61(6):584-5. PubMed ID: 2369402
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of transdermal scopolamine on simulated ship navigation and attention/reaction time.
    Howland J, Rohsenow DJ, Minsky S, Snoberg J, Tagerud S, Hunt SK, Almeida A, Greece J, Allensworth-Davies D.
    Int J Occup Environ Health; 2008 Jun 15; 14(4):250-6. PubMed ID: 19043911
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transdermal scopolamine psychosis.
    Osterholm RK, Camoriano JK.
    JAMA; 1982 Jun 11; 247(22):3081. PubMed ID: 7077797
    [No Abstract] [Full Text] [Related]

  • 17. Control of simulator sickness in an AH-64 aviator.
    Kroll JD.
    Aviat Space Environ Med; 1989 Dec 11; 60(12):1202-3. PubMed ID: 2604677
    [Abstract] [Full Text] [Related]

  • 18. [Anisocoria following use of the scopoderm disc].
    Hartmann B, Miloh R, Zer I, Kam J.
    Harefuah; 1988 Nov 15; 115(10):276-7. PubMed ID: 3234961
    [No Abstract] [Full Text] [Related]

  • 19. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
    Homick JL, Kohl RL, Reschke MF, Degioanni J, Cintron-Trevino NM.
    Aviat Space Environ Med; 1983 Nov 15; 54(11):994-1000. PubMed ID: 6651736
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.